Skip to main content

Table 3 ORR of FOLFIRINOX and nabPGem in 1st and 2nd line

From: Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Efficacy parameter FOLFIRINOX (n = 55) nabPGem (n = 76)
1st-line 2nd-line 1st-line 2nd-line
(n = 42) (n = 13) (n = 41) (n = 35)
Response rate n (%) n (%) n (%) n (%)
 PR 18 (43) 3 (23) 8 (20) 3 (9)
 SD 19 (45) 7 (54) 22 (54) 19 (54)
 PD 5 (12) 3 (23) 11 (27) 13 (37)